Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 256
7
Diseases
26
Unique genes
0.544
Avg. similarity score
Gilbert syndrome
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Gilbert syndrome
Bilirubin metabolism disease
Crigler-najjar syndrome
Lucey-driscoll syndrome
Perinatal disease
Rotor syndrome
Hyperbilirubinemia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Gilbert syndrome | 6 | 6 | 10 |
| Bilirubin metabolism disease | 5 | 5 | 12 |
| Crigler-najjar syndrome | 4 | 4 | 9 |
| Lucey-driscoll syndrome | 4 | 4 | 9 |
| Perinatal disease | 4 | 4 | 10 |
| Rotor syndrome | 3 | 3 | 3 |
| Hyperbilirubinemia | 2 | 2 | 13 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| UGT1A1 | 5 / 7 | Crigler-najjar syndrome, Gilbert syndrome, Hyperbilirubinemia, Lucey-driscoll syndrome and 1 more |
| UGT1A10 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A3 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A4 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A5 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A6 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A7 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A8 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| UGT1A9 | 5 / 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Lucey-driscoll syndrome and 1 more |
| SLCO1B1 | 4 / 7 | Bilirubin metabolism disease, Gilbert syndrome, Hyperbilirubinemia, Rotor syndrome |
| SLCO1B3 | 2 / 7 | Hyperbilirubinemia, Rotor syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bile secretion | KEGG | 13 / 90 | 66.7× | 9.16e-22 | 9.83e-19 ✓ sig. |
| Glucuronidation | Reactome | 9 / 22 | 189× | 1.07e-19 | 7.99e-17 ✓ sig. |
| Ascorbate and aldarate metabolism | KEGG | 9 / 30 | 139× | 3.05e-18 | 1.84e-15 ✓ sig. |
| Pentose and glucuronate interconversions | KEGG | 9 / 36 | 115× | 1.99e-17 | 1.02e-14 ✓ sig. |
| Porphyrin metabolism | KEGG | 9 / 46 | 90.4× | 2.30e-16 | 9.92e-14 ✓ sig. |
| Drug metabolism - other enzymes | KEGG | 10 / 81 | 57.0× | 5.34e-16 | 2.18e-13 ✓ sig. |
| Steroid hormone biosynthesis | KEGG | 9 / 63 | 66.0× | 4.83e-15 | 1.63e-12 ✓ sig. |
| Retinol metabolism | KEGG | 9 / 68 | 61.1× | 1.00e-14 | 3.12e-12 ✓ sig. |
| Chemical carcinogenesis - DNA adducts | KEGG | 9 / 70 | 59.4× | 1.32e-14 | 3.98e-12 ✓ sig. |
| Drug metabolism - cytochrome P450 | KEGG | 9 / 73 | 56.9× | 1.96e-14 | 5.72e-12 ✓ sig. |
| Metabolism of xenobiotics by cytochrome P450 | KEGG | 9 / 79 | 52.6× | 4.12e-14 | 1.12e-11 ✓ sig. |
| Biosynthesis of cofactors | KEGG | 9 / 154 | 27.0× | 1.92e-11 | 3.25e-9 ✓ sig. |
| Chemical carcinogenesis - receptor activation | KEGG | 9 / 215 | 19.3× | 3.83e-10 | 4.80e-8 ✓ sig. |
| Heme degradation | Reactome | 4 / 14 | 132× | 1.70e-8 | 1.39e-6 ✓ sig. |
| Folate transport and metabolism | KEGG | 4 / 31 | 59.6× | 5.22e-7 | 2.78e-5 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| negative regulation of fatty acid metabolic process | GO:0045922 | 9 / 11 | 588× | 2.24e-25 | 7.41e-22 ✓ sig. |
| xenobiotic metabolic process | GO:0006805 | 11 / 120 | 65.9× | 3.41e-18 | 4.19e-15 ✓ sig. |
| flavone metabolic process | GO:0051552 | 5 / 5 | 719× | 3.47e-15 | 2.49e-12 ✓ sig. |
| flavonoid metabolic process | GO:0009812 | 5 / 12 | 299× | 2.73e-12 | 1.14e-9 ✓ sig. |
| retinoic acid metabolic process | GO:0042573 | 5 / 25 | 144× | 1.81e-10 | 4.90e-8 ✓ sig. |
| heme catabolic process | GO:0042167 | 4 / 11 | 261× | 9.65e-10 | 2.17e-7 ✓ sig. |
| liver development | GO:0001889 | 6 / 87 | 49.6× | 1.83e-9 | 3.82e-7 ✓ sig. |
| steroid metabolic process | GO:0008202 | 5 / 135 | 26.6× | 1.06e-6 | 8.71e-5 ✓ sig. |
| bilirubin conjugation | GO:0006789 | 2 / 2 | 719× | 1.86e-6 | 1.36e-4 ✓ sig. |
| vitamin D3 metabolic process | GO:0070640 | 2 / 3 | 479× | 5.58e-6 | 3.27e-4 ✓ sig. |
| toxin catabolic process | GO:0009407 | 2 / 3 | 479× | 5.58e-6 | 3.27e-4 ✓ sig. |
| negative regulation of steroid metabolic process | GO:0045939 | 2 / 3 | 479× | 5.58e-6 | 3.27e-4 ✓ sig. |
| bile acid and bile salt transport | GO:0015721 | 3 / 26 | 82.9× | 6.09e-6 | 3.51e-4 ✓ sig. |
| estrogen metabolic process | GO:0008210 | 3 / 30 | 71.9× | 9.47e-6 | 5.01e-4 ✓ sig. |
| response to isolation stress | GO:0035900 | 2 / 4 | 359× | 1.11e-5 | 5.66e-4 ✓ sig. |